Sintx Technologies (SINT) Total Debt Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.11% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 1.72% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.34% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -14.39% |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 | -40.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.52% |
| Dec 31, 2025 | -89.16% |
| Sep 30, 2025 | 50.74% |
| Jun 30, 2025 | -17.62% |
| Mar 31, 2025 | 33.80% |
| Dec 31, 2024 | 37.50% |
| Sep 30, 2024 | -35.91% |
| Jun 30, 2024 | -22.11% |
| Mar 31, 2024 | -23.18% |
| Dec 31, 2023 | -41.58% |
| Sep 30, 2023 | 19.57% |
| Jun 30, 2023 | 36.21% |
| Mar 31, 2023 | 40.12% |
| Dec 31, 2022 | 573.29% |
| Sep 30, 2022 | 129.55% |
| Jun 30, 2022 | -24.55% |
| Mar 31, 2022 | -31.64% |
| Dec 31, 2021 | -32.51% |
| Sep 30, 2021 | -31.24% |
| Jun 30, 2021 | -56.18% |
| Mar 31, 2021 | -37.40% |
| Dec 31, 2020 | 36.09% |
| Sep 30, 2020 | -27.31% |
| Mar 31, 2020 | -27.34% |
| Dec 31, 2019 | -82.10% |
| Sep 30, 2019 | -84.66% |
| Jun 30, 2019 | -65.60% |
| Dec 31, 2018 | -59.81% |
| Sep 30, 2018 | -57.20% |
| Jun 30, 2018 | -35.46% |
| Mar 31, 2018 | -54.52% |
| Dec 31, 2017 | -69.88% |
| Sep 30, 2017 | -64.32% |
| Mar 31, 2017 | -48.69% |
| Dec 31, 2016 | -44.06% |